<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083793</url>
  </required_header>
  <id_info>
    <org_study_id>17101526</org_study_id>
    <nct_id>NCT05083793</nct_id>
  </id_info>
  <brief_title>the Effect of Pregabalin on Postoperative Pain and Opioid Consumption in Spine Surgery</brief_title>
  <official_title>The Effect of Pregabalin on Post-operative Pain and Opioid Consumption in Spine Surgery, a Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of pregabalin on post-operative pain and opioid consumption in spine surgery, a&#xD;
      prospective, randomized, controlled study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the work:&#xD;
&#xD;
      The aim of our study is to compare the analgesic effect of pre-emptive oral pregabalin 150mg&#xD;
      on acute postoperative pain and opioid consumption in spine surgery. Evaluated by visual&#xD;
      analog scale (VAS)&#xD;
&#xD;
      primary outcome measure is the total amount of rescue morphine received by patients for 24h&#xD;
      postoperatively.&#xD;
&#xD;
      secondary outcome measures include level of acute postoperative pain by VAS, and duration of&#xD;
      hospital stay&#xD;
&#xD;
      Patients and methods :&#xD;
&#xD;
      This study will be carried out after being approved from the Medical Research Ethical&#xD;
      Committee, Faculty of Medicine, Assiut University, Assiut, Egypt, and after obtaining a&#xD;
      written informed consents from all participating patients.&#xD;
&#xD;
      inclusion criteria: This prospective randomized clinical study will include eighty patients&#xD;
      with ASA I-II, aged 18-60 years scheduled for spine surgery&#xD;
&#xD;
      Exclusion criteria : Excluded from the study are patients with known allergy to the study&#xD;
      drugs, significant cardiac, respiratory, renal, CNS or hepatic disease, drug or alcohol&#xD;
      abuse, pregnant women, patients refusing participation and psychiatric or mental illness that&#xD;
      would interfere with perception and assessment of pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>care provider</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Morphia dose</measure>
    <time_frame>24 hour postoperative</time_frame>
    <description>the total amount of rescue morphine received by patients for 24h postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>24 hour postoperative</time_frame>
    <description>post operative VAS score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients have spine surgery receive oral pregabalin 150 mg 1 hour before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients will receive placebo 1 hour before surgery with a sip of water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin 150mg</intervention_name>
    <description>The effect of pregabalin on post-operative pain</description>
    <arm_group_label>Study group</arm_group_label>
    <other_name>Pregabalin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>patients will receive placebo one hour before operation</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  : This prospective randomized clinical study will include eighty patients with ASA&#xD;
             I-II, aged 18-60 years scheduled for spine surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  : Excluded from the study are patients with known allergy to the study drugs,&#xD;
             significant cardiac, respiratory, renal, CNS or hepatic disease, drug or alcohol&#xD;
             abuse, pregnant women, patients refusing participation and psychiatric or mental&#xD;
             illness that would interfere with perception and assessment of pain.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Maher, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mahmoud Maher</name>
      <address>
        <city>Assiut</city>
        <zip>11174</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/15315511/</url>
    <description>Pregabalin pharmacology and its relevance to clinical practice</description>
  </link>
  <reference>
    <citation>Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45 Suppl 6:13-8. Review.</citation>
    <PMID>15315511</PMID>
  </reference>
  <reference>
    <citation>Hindmarch I, Trick L, Ridout F. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl). 2005 Dec;183(2):133-43. Epub 2005 Nov 9.</citation>
    <PMID>16205916</PMID>
  </reference>
  <reference>
    <citation>Sebastian B, Talikoti AT, Nelamangala K, Krishnamurthy D. Effect of Oral Pregabalin as Preemptive Analgesic in Patients Undergoing Lower Limb Orthopedic Surgeries under Spinal Anaesthesia. J Clin Diagn Res. 2016 Jul;10(7):UC01-4. doi: 10.7860/JCDR/2016/18854.8081. Epub 2016 Jul 1.</citation>
    <PMID>27630927</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed galal aly</investigator_full_name>
    <investigator_title>Professor of anesthesia and intensive care</investigator_title>
  </responsible_party>
  <keyword>pregabalin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>make individual participant data (IPD) available to other researchers</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>one year</ipd_time_frame>
    <ipd_access_criteria>Study protocol</ipd_access_criteria>
    <ipd_url>https://pubmed.ncbi.nlm.nih.gov/15315511/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

